Article 4 Explained: Why It's Secretly Making Existing HMOs More Valuable

What Article 4 Actually Does (And Doesn't Do)

Start with the mechanics, because most of the fear around Article 4 comes from people who've half-read a planning notice and filled in the gaps with dread.

Under the General Permitted Development Order 2015 (GPDO 2015), Class L Part 3, a landlord can convert a standard residential dwelling — use class C3 — into a small HMO of 3 to 6 unrelated occupants — use class C4 — without applying for full planning permission. That's the permitted development (PD) right. It's a shortcut. It means you don't need to go cap in hand to the council.

An Article 4 Direction removes that shortcut. Nothing more.

It does not ban HMOs. It does not retroactively strip existing HMOs of their lawful use. It does not require existing operators to do anything differently on Monday morning. What it does is force anyone wanting to create a new C4 HMO in the designated area to submit a full planning application and wait for a decision — with no guarantee of approval.

According to RealYield's June 2026 analysis, the C4 classification covers small HMOs of 3 to 6 unrelated people, while properties housing 7 or more fall into Sui Generis — a separate use class that has always required full planning permission regardless of Article 4. So Article 4 specifically targets the most common conversion route: family home to small shared house.

The Scarcity Engine Nobody Talks About

Here's where the counterintuitive part kicks in — and why I think most commentary on Article 4 completely misses the point.

When a council designates an Article 4 area, supply of new HMOs in that area is effectively capped. Planning applications for C3-to-C4 conversions get refused at high rates in most Article 4 zones, because the whole point of the direction is to control HMO density. Mayfair Studio's April 2026 market review noted that over 22 London boroughs now operate Article 4 Directions covering HMOs — including blanket coverage in Newham, Barnet, and Tower Hamlets, with partial coverage in Lambeth and Haringey. Add Manchester, Leeds, Birmingham, Bristol, Nottingham, and Southampton to that list and you're looking at a significant chunk of the UK's highest-demand rental markets.

So what happens to the HMOs that were already lawfully operating before the direction came in?

They inherit scarcity value. Full stop.

Demand for shared housing in those cities hasn't dropped — if anything, affordability pressures have pushed more renters into the HMO market. But the supply side is now structurally constrained. Existing licensed HMOs in Article 4 zones become a finite pool. And a finite pool of income-generating assets in high-demand locations is, by any rational measure, worth more than an unlimited one.

The HMO Mortgage Broker Report flagged this explicitly: Article 4 restrictions on new supply are actively supporting yields on existing stock. That's not spin. That's basic economics.

Why New Investors Get This Backwards

New investors hear 'Article 4 area' and immediately think: danger zone. Avoid.

I get it. The language sounds prohibitive. 'Direction.' 'Restriction.' 'Removal of permitted development rights.' It reads like a warning label.

But the investors I see making that mistake are confusing two completely different positions: the position of someone trying to create a new HMO in an Article 4 area, and the position of someone buying an existing, lawfully established HMO in one.

If you're trying to convert a family home in Tower Hamlets into a six-bed HMO today, yes — you face a planning application, probable refusal, and a frustrating process. Article 4 is your enemy.

If you're buying a property that's already operating as a licensed C4 HMO in Tower Hamlets, you're buying an asset that cannot be easily replicated. The planning protection is baked in. The use is established. You're not fighting the system — you're benefiting from the wall it built around you.

The practical implication: due diligence matters enormously here. Before acquiring any HMO in an Article 4 area, confirm the lawful use is properly established — check the existing planning history, the HMO licence, and if there's any doubt, consider consulting a qualified solicitor who specialises in planning law. Getting this wrong is expensive. Getting it right is a genuine competitive moat.

Finding Already-Licensed HMOs in Article 4 Zones

The practical problem — and this is where I'll be direct about what I think is the biggest friction point for investors — is finding these properties.

Standard property portals don't filter by HMO licence status. They don't tell you whether a property sits inside an Article 4 designation. They don't distinguish between a C4-established HMO and a house that someone is optimistically marketing as a 'potential HMO opportunity' in an area where that conversion is now effectively blocked.

This is exactly the gap that [ZARSK](https://zarsk.co.uk/) is built to address. The database — which I believe is the largest dedicated HMO database in the UK, and it's constantly updated — lets you search for HMOs in specific areas, including those already operating under licence in Article 4 zones. That kind of targeted search simply doesn't exist on the mainstream portals. You're not sifting through thousands of irrelevant listings hoping to stumble across something suitable.

And once you've identified a target property, the next challenge is financing it. HMO mortgages are a specialist product. Lenders assess them differently from standard buy-to-let, they stress-test yields differently, and for investors trying to free up equity in an existing portfolio to fund the next acquisition — whether that's a standard BTL or an existing HMO book — the options are genuinely more complex than most brokers acknowledge. The regulated finance partners at [ZARSK's finance hub](https://www.zarsk.co.uk/finance-property) have been working in this space for over a decade. Freeing equity from an existing portfolio is hard; having a team that knows the specific lenders, the specific criteria, and the specific structures that work for HMO investors makes a material difference.

Article 4 is going to expand. More councils will adopt it, not fewer — the political pressure to control HMO density in urban areas isn't going away. Every new designation that lands makes the existing, lawfully established stock in that area marginally more valuable. Investors who understand that mechanism now are positioning themselves ahead of a trend that's still being misread as bad news by the majority of the market. The question isn't whether Article 4 areas are worth investing in. The question is whether you can find the right stock before everyone else figures out what you already know.